Literature DB >> 2862892

The effect of acute beta-adrenoceptor blockade on examination performance.

P J Drew, J N Barnes, S J Evans.   

Abstract

Simple tests of verbal reasoning and mental arithmetic, taken under mildly stressful conditions, have been shown to give a reproducible test of intellectual function within groups of normal subjects. Using these tests, in two separate examinations, a double-blind cross-over study was performed on 35 medical students to assess the effects of acute beta-adrenoceptor blockade with propranolol on intellectual function. With placebo treatment, students recorded an average total score of 231.3 marks, with average scores of 108.9 marks on the mental arithmetic paper and 122.4 marks on the verbal reasoning paper. Treatment with propranolol was associated with an improvement in total score of 9.2 +/- 3.9 marks (P less than 0.05), an improvement in mental arithmetic score of 5.6 +/- 2.3 marks (P less than 0.05) and an improvement in verbal reasoning score of 3.6 +/- 2.4 marks (NS). Eighteen out of the 35 students said that they were mildly anxious before one examination and 13 students said they were anxious before both examinations. Those students who admitted anxiety seemed to benefit the most, in terms of improved examination performance, from treatment with propranolol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862892      PMCID: PMC1463865          DOI: 10.1111/j.1365-2125.1985.tb02714.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Beneficial effect of beta-adrenergic blockade on "exam. nerves".

Authors:  C Brewer
Journal:  Lancet       Date:  1972-08-26       Impact factor: 79.321

2.  Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine.

Authors:  D B Jack; S Dean; M J Kendall
Journal:  J Chromatogr       Date:  1980-01-04

3.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

4.  Effect of oxprenolol on stage-fright in musicians.

Authors:  I M James; D N Griffith; R M Pearson; P Newbury
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

Review 5.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

7.  Effect of pindolol on stress-related disturbances of musical performance: preliminary communication.

Authors:  I M James; W Burgoyne; I T Savage
Journal:  J R Soc Med       Date:  1983-03       Impact factor: 18.000

8.  Treatment of hypertension with beta-adrenoceptor blocking drugs.

Authors:  T R Bai; D Webb; M Hamilton
Journal:  J R Coll Physicians Lond       Date:  1982-10
  8 in total
  11 in total

1.  Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility.

Authors:  Heather L Campbell; Madalina E Tivarus; Ashleigh Hillier; David Q Beversdorf
Journal:  Pharmacol Biochem Behav       Date:  2007-08-19       Impact factor: 3.533

2.  Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats.

Authors:  Safiyya Zaidi; Fatin Atrooz; Daniel Valdez; Hesong Liu; Camila Kochi; Richard A Bond; Samina Salim
Journal:  Neurosci Lett       Date:  2020-03-09       Impact factor: 3.046

3.  β-Adrenergic Contributions to Emotion and Physiology During an Acute Psychosocial Stressor.

Authors:  Jennifer K MacCormack; Emma L Armstrong-Carter; Monica M Gaudier-Diaz; Samantha Meltzer-Brody; Erica K Sloan; Kristen A Lindquist; Keely A Muscatell
Journal:  Psychosom Med       Date:  2021 Nov-Dec 01       Impact factor: 4.312

4.  Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh.

Authors:  Abdulelah Adnan Abukhalaf; Ali Abdullah Alomar; Nayef Mosleh Alsalame; Omar Yassin Sumaya; Omar Mohammed Alessa; Majed Mohammed Alasbali; Yasser A Alaska
Journal:  J Family Med Prim Care       Date:  2020-08-25

5.  Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients.

Authors:  Monica E Lindgren; Christopher P Fagundes; Catherine M Alfano; Stephen P Povoski; Doreen M Agnese; Mark W Arnold; William B Farrar; Lisa D Yee; William E Carson; Carl R Schmidt; Janice K Kiecolt-Glaser
Journal:  Psychooncology       Date:  2012-12-17       Impact factor: 3.894

6.  Propranolol Decreases Fear Expression by Modulating Fear Memory Traces.

Authors:  Sofia Leal Santos; Michelle Stackmann; Andrea Muñoz Zamora; Alessia Mastrodonato; Allegra V De Landri; Nick Vaughan; Briana K Chen; Marcos Lanio; Christine A Denny
Journal:  Biol Psychiatry       Date:  2021-01-20       Impact factor: 12.810

Review 7.  Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis.

Authors:  Serge A Steenen; Arjen J van Wijk; Geert J M G van der Heijden; Roos van Westrhenen; Jan de Lange; Ad de Jongh
Journal:  J Psychopharmacol       Date:  2015-10-20       Impact factor: 4.153

Review 8.  Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

9.  A National Survey of Self-Prescription of Beta-Blockers and Their Relation to Undiscovered Anxiety Among Medical and Pharmacological Students in Saudi Arabia.

Authors:  Albaraa Alsini; Ishraq Alkhodaidi; Yasir Alsini; Sarh Alsseeni; Shrooq Alkhodaidi; Ehsan Alsini; Asim Alsini; Hamzah Sindi; Khaled Alswat
Journal:  Neuropsychiatr Dis Treat       Date:  2021-03-17       Impact factor: 2.570

10.  Effects of propranolol on fear of dental extraction: study protocol for a randomized controlled trial.

Authors:  Serge A Steenen; Arjen J van Wijk; Roos van Westrhenen; Jan de Lange; Ad de Jongh
Journal:  Trials       Date:  2015-11-25       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.